The hemolytic uremic syndrome as a complication of adriamycin nephropathy

Renal Failure

Volumn 20, Issue 4, 1998, Pages 565-571

  Viero, Rosa Marlene ^a   Soares, Vitor A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adriamycin; Hemolytic uremic syndrome

Indexed keywords

DOXORUBICIN; HYDROXYPROLINE; SERUM ALBUMIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HEMOLYTIC UREMIC SYNDROME; INTERSTITIAL NEPHRITIS; KIDNEY ARTERY; KIDNEY DISEASE; MALE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031853810     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045148     Document Type: Article

References (17)

1. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H: The association of between idiopathic hemolytic uremic syndrome and infection by verotoxin producing Escherichia Coli. J Infec Dis 151:775-782, 1985.
2. Lindheimer MD, Katz AL: Preeclampsia: Pathophysiology, diagnosis and management. Ann Rev Med 40:233-250, 1989.
3. Segonds A, Louradour N, Suc JM, Orfila C: Post-partum hemolytic uremic syndrome: A study of three cases review of the literature. Clin Nephrol 12:229-242, 1979.
4. Milford DV, Goldstein A, Barret M, Mann Jr, Raafat F: Cancer associated hemolytic uremic syndrome developing prior to treatment with cytotoxic agents. Med Pediatr Oncol 21:142-145, 1993.
5. Bondsteiner DC, Doolitle GC: Adverse haematological complication of anticancer drugs. Clinical presentation, management and avoidance. Drug Safe 8:213-224, 1993.
6. Boccia RV, Gelmann EP, Baker CC, Martin G, Longo DL: Hemolytic uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med 101:716-717, 1984.
7. Okuda S, Oh Y, Tsuruda H, Onayama H, Onayama K, Fujimi S, Fujishima M: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502-510, 1986.
8. Remuza G, Imberti L, Rossini M, Morelli C, Carminatti C, Cathaneo GM, Bertani T: Increased glomerular thromboxane synthesis as a possible cause. J Clin Invest 75:94-101, 1985.
9. Switzer BR: Determination of hydroxiproline in tissue. J Nutr Biochem 2:229-231, 1991.
10. Remuzzi G, Ruggenenti P, Bertani T: Thrombotic microangiopathy. In: Tisher CC, Brenner BM (eds.); Renal Pathology with Clinical and Functional Correlations. 2nd ed. Philadelphia, JB Lippincott Company, 1994, pp 1154-1185.
11. Mergenthaler HG, Besnack T, Welmanns W: Carcinoma-associated hemolytic- uremic syndrome in a patient receiving 5-fluoruracil-adriamycin-mitomycin C combination therapy. Oncology 45:11-14, 1988.
12. Kambhu SA, Kelsen DP, Fiore J, Niedzwiecki D, Chapman D, Vinciguena V, Rosenbluth R: Metastatic adenocarcinoma of unknown primary site. Prognostic variables and treatment results. Am J Clin Oncol 13:55-60, 1990.
13. Hillyerd CD, Duncan A, Ledford M, Barrett TJ, Klumpp SA, Anderson DC, McClure HM, Winton EF: Chemotherapy-induced hemolytic uremic syndrome: description of a potential animal model. J Med Primatol 24:68-73, 1995
14. Cattel V: Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat. Am J Pathol 121:88-95, 1985
15. D'Agatti V, Cheng JI, Carbone I, Cheng JT, Appel G: The pathology of HIV nephropathy: A detailed morphologic and comparative study. Kidney Int 35:1358-1370, 1989.
16. Mayo J, Collazos J, Martinez E: Thrombotic microangiopathy related to infection in an HIV-positive patient. Eur J Clin Microbiol Infect Dis 15:254-256, 1996.
17. Kelleher P, Severn A, Tomson C, Lucas S, Parkin J, Pinching A, Miller R: The haemolytic uraemic syndrome in patients with AIDS. Genitourin Med 72:172-175, 1996.